Sandoz Group (OTCMKTS:SDZNY) Stock Price Up 1.6% - Here's What Happened

Key Points

• Sandoz Group's shares increased by 1.6% during trading, reaching a last price of $63.11, after previously closing at $62.12.
• Analysts have mixed views on Sandoz Group, with Jefferies downgrading the stock from "strong-buy" to "hold", while Royal Bank of Canada upgraded it from "hold" to "moderate buy".
• The company's debt-to-equity ratio stands at 0.57, and its quick and current ratios are 0.79 and 1.24 respectively, indicating a solid financial health.

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY - Get Free Report)'s stock price shot up 1.6% on Wednesday . The company traded as high as $63.19 and last traded at $63.11. 19,997 shares were traded during mid-day trading, a decline of 13% from the average session volume of 22,963 shares. The stock had previously closed at $62.12.

Analysts Set New Price Targets

Separately, Jefferies Financial Group cut shares of Sandoz Group from a "strong-buy" rating to a "hold" rating in a report on Friday, August 8th. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, Sandoz Group presently has an average rating of "Hold".

Sandoz Group Stock Down 2.3%

The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.79 and a current ratio of 1.24. The firm's 50 day simple moving average is $58.15 and its 200 day simple moving average is $49.68.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.